About Simimed, Inc.
My Mission
I will do as much as possible to advance the state of the art in medical devices to mitigate chronic diseases. For more than two decades, I have focused on the wellness of people managing diabetes.
Professional Experience
Insulet Corporation
Consultant, and VP Hardware and Advanced Technology
Insulet is the world-leader in disposable, tubeless insulin pumps and hybrid closed-loop systems.
Optiscan Biomedical
VP R&D, Innovation
We developed the first FDA-cleared (K162042), optical-based continuous glucose monitor for critical care. The technology is mid-infrared spectroscopy.
Simimed, Inc.
President
Services provided: testifying expert for Fish & Richardson in Baxter v. Fresenius; and as the testifying expert in a U.K. court: Insulet v. Roche.
M2 Medical
CEO/President
Brought a new insulin pump project incubated in Denmark to Silicon Valley; staffed with local talent. Funding was initially Novo Ventures; raised $26M in a Series-A. The company was re-branded to Asante, sold to BigFoot Biomedical, and ultimately its IP assets were acquired by Insulet.
Fish & Richardson
Testifying Expert
Testifying expert for Fish & Richardson for defendant in Baxter v. Fresenius.
Warburg Pincus
Venture Investor Consultant
Warbug Pincus my first equity investor relationship: investigating glucose sensors and novel insulin pumps. Consulted for the Helmsley Trust in reviewing novel infusion pump technologies, including an example from Dean Kamen’s DEKA.
MiniMed Inc.
VP R&D
Led R&D in the development of a line of insulin pumps; kept promises to investors regarding submission timelines. Applying both evolutionary changes, and revolutionary innovation, brought a new pump platform that endured for a decade.
Simianalytica (a unit of Simimed, Inc.)
Subscription Blog, Free or Fee
The author shares timely insights in medical devices. The content frequently includes core ideas to seed inventions.